Advertisement
Australia markets close in 50 minutes
  • ALL ORDS

    8,047.20
    +94.90 (+1.19%)
     
  • ASX 200

    7,774.80
    +92.40 (+1.20%)
     
  • AUD/USD

    0.6612
    -0.0013 (-0.20%)
     
  • OIL

    78.62
    +0.14 (+0.18%)
     
  • GOLD

    2,330.70
    -0.50 (-0.02%)
     
  • Bitcoin AUD

    95,915.87
    -1,224.72 (-1.26%)
     
  • CMC Crypto 200

    1,363.87
    +51.24 (+3.90%)
     
  • AUD/EUR

    0.6138
    -0.0008 (-0.13%)
     
  • AUD/NZD

    1.0996
    -0.0025 (-0.22%)
     
  • NZX 50

    11,800.78
    -20.00 (-0.17%)
     
  • NASDAQ

    18,093.57
    +202.77 (+1.13%)
     
  • FTSE

    8,213.49
    +41.34 (+0.51%)
     
  • Dow Jones

    38,852.27
    +176.59 (+0.46%)
     
  • DAX

    18,175.21
    +173.61 (+0.96%)
     
  • Hang Seng

    18,453.86
    -124.44 (-0.67%)
     
  • NIKKEI 225

    38,686.35
    +450.28 (+1.18%)
     

NanoString to Webcast Presentation from Jefferies Healthcare Conference

SEATTLE, May 31, 2023--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the Jefferies Healthcare Conference, which will be held June 7-9, 2023.

Brad Gray, president and chief executive officer, is scheduled to present on Thursday, June 8, 2023, at 8:30am ET. Interested parties can access the live webcast from the investor section of the company’s website at www.nanostring.com. The webcast replay will be available one hour after the conclusion of the live presentation and archived for 30 days.

About NanoString

NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions, empowering our customers to map the universe of biology. The GeoMx® Digital Spatial Profiler is a flexible and consistent solution combining the power of whole tissue imaging with gene expression and protein data for spatial whole transcriptomics and proteomics. The CosMx™ Spatial Molecular Imager is a single-cell imaging platform powered by spatial multiomics enabling researchers to map single cells in their native environments to extract deep biological insights and novel discoveries from one experiment. The AtoMx™ Spatial Informatics Platform is a cloud-based informatics solution with advanced analytics and global collaboration capabilities, enabling powerful spatial biology insights anytime, anywhere. At the foundation of our research tools is our nCounter® Analysis System, which offers a secure way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision.

ADVERTISEMENT

For more information, please visit www.nanostring.com.

NanoString, NanoString Technologies, the NanoString logo, GeoMx, AtoMx and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230531005399/en/

Contacts

Doug Farrell
Vice President, Investor Relations & Corporate Communications
dfarrell@nanostring.com
Phone: 206-602-1768